Release of Interleukins and Other Inflammatory Cytokines by Human Adipose Tissue Is Enhanced in Obesity and Primarily due to the Nonfat Cells

Vitamins and Hormones

Volumn 74, Issue , 2006, Pages 443-477

  Fain, John N ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN DERIVATIVE;

ADIPOSE TISSUE; ANIMAL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; OBESITY; RAT; REVIEW; SECRETION;

ADIPOSE TISSUE; ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKINS; OBESITY; RATS;

EID: 33846201363     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(06)74018-3     Document Type: Review

References (142)

1. Alessi M.C., Peiretti F., Morange P., Henry M., Nalbone G., and Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue. Diabetes 46 (1997) 860-867
2. Alessi M.C., Bastelica D., Morange P., Berthet B., Leduc I., Verdier M., Geel O., and Juhan-Vague I. Plasminogen activator inhibitor 1, transforming growth factor-β1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49 (2000) 1374-1380
3. Bastard J.-P., Jardel C., Delattre J., Hainque B., Brucker E., and Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99 (1999) 2221-2222
4. Bastard J.-P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., Robert J.-J., Capeau J., and Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 87 (2002) 2084-2089
5. Bastelica D., Mavri A., Verdierl M., Berthet B., Juhan-Vague I., and Alessi M.C. Relationships between fibrinolytic and inflammatory parameters in human adipose tissue: Strong contribution of TNFα receptors to PAI-1 levels. Thromb. Haemost. 88 (2002) 481-487
6. Beloqui O., Paramo J.A., Orbe J., Benito A., Colina I., Monasterio A., and Diez J. Monocyte cyclooxygenase-2 overactivity: A new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?. Eur. Heart J. 26 (2005) 153-158
7. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Cir. Res. 96 (2005) 939-949
8. Blankenberg S., Tiret L., Bickel C., Peetz D., Cambien F., Meyer J., and Rupprecht H.J. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106 (2002) 24-30
9. Boekholdt S.M., Peters R.J.G., Hack C.E., Day N.E., Luben R., Bingham S.A., Wareham N.J., Reitsma P.H., and Khaw K.-T. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1503-1508
10. Bruun J.M., Pedersen S.B., and Richelsen B. Regulation of Interleukin 8 production and gene expression in human adipose tissue in vitro. J. Clin. Endocrinol. Metab. 86 (2001) 1267-1273
11. Bruun J.M., Verdich C., Toubro S., Astrup A., and Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α. Effect of weight loss in obese men. Eur. J. Endocrinol. 148 (2003) 535-542
12. Bruun J.M., Lihn A.S., Madan A.K., Pedersen S.B., Schiott K.M., Fain J.N., and Richelsen B. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E8-E13
13. Bruun J.M., Lihn A.S., Pedersen S.B., and Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): Implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 90 (2005) 2282-2289
14. Carey A.L., and Febbraio M.A. Interleukin-6 and insulin sensitivity: Friend or foe?. Diabetologia 47 (2004) 1135-1142
15. Carr M.C., and Brunzell J.D. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J. Clin. Endocrinol. Metab. 89 (2004) 2601-2607
16. Charriere G., Cousin B., Arnaud E., Andre M., Bacou F., Penicaud L., and Casteilla L. Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem. 278 (2003) 9850-9855
17. Chen C.C., Li T.C., Li C.I., Liu C.S., Wang J.J., and Lin C.C. Serum resistin level among healthy subjects: Relationship to anthropometric and metabolic parameters. Metabolism 54 (2005) 471-475
18. Christiansen T., Richelsen B., and Bruun J.M. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int. J. Obes. (Lond.) 29 (2005) 146-150
19. Church T.S., Willis M.S., Priest E.L., Lamonte M.J., Earnest C.P., Wilkinson W.J., Wilson D.A., and Giroir B.P. Obesity, macrophage migration inhibitory factor, and weight loss. Int. J. Obes. (Lond.) 29 (2005) 675-681
20. Claffey K.P., Wilkison W.O., and Spiegelman B.M. Vascular endothelial growth factor: Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267 (1992) 16317-16322
21. Corbetta S., Bulfamante G., Cortelazzi D., Barresi V., Cetin I., Mantovani G., Bondioni S., Beck-Peccoz P., and Spada A. Adiponectin expression in human fetal tissues during mid- and late gestation. J. Clin. Endocrinol. Metab. 90 (2005) 2397-2402
22. Corica F., Allegra A., Buemi M., Corsonello A., Bonanzinga S., Rubino F., Castagna L., and Ceruso D. Reduced plasma concentrations of transforming growth factor β1 (TGF-β1) in obese women. Int. J. Obes. (Lond.) 21 (1997) 704-707
23. Cottam D.R., Mattar S.G., Barinas-Mitchell E., Eid G., Kuller L., Kelley D.E., and Schauer P.R. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effects of weight loss. Obes. Surg. 14 (2004) 589-600
24. Curtis-Prior P.B., Jenner M., Smethurst M., and Woodward J.W. Plasma prostaglandin levels in fed and starved lean, normal and obese women. Experientia 35 (1979) 911-912
25. Dandona P., Aljada A., Ghanim H., Mohanty P., Tripathy C., Hofmeyer D., and Chaudhuri A. Increased plasma concentration of macrophage migration factor (MIF) and MIF mRNA in monocuclear cells in the obese and the suppressive action of metformin. J. Clin. Endocrinol. Metab. 89 (2004) 5043-5047
26. Danesh J., Muir J., Wong Y.K., Ward M., Gallimore J.R., and Pepys M.B. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur. Heart J. 20 (1999) 954-959
27. Di Gregorio G.B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L.M., Ranganathan G., Peterson C.A., McGehee R.E., and Kern P.A. Expression of CD68 and macrophase chemoattractant protein-1 genes in human adipose tissues: Association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54 (2005) 2305-2313
28. Engeli S., Feldpausch M., Gorzelniak K., Hartwig F., Heintze U., Janke J., Mohlig M., Pfeiffer A.F., Luft F.C., and Sharma A.M. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52 (2003) 942-947
29. Esposito K., Pontillo A., Ciotola M., di Paolo C., Grella E., Nicoletti G., and Giugliano D. Weight loss reduces interleukin-18 levels in obese women. J. Clin. Endocrinol. Metab. 87 (2002) 3864-3866
30. Esposito K., Pontillo A., Giugliano F., Giugliano G., Marfella R., Nicoletti G., and Giugliano D. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J. Clin. Endocrinol. Metab. 88 (2003) 1055-1058
31. Fain J.N., and Bahouth S.W. Regulation of leptin release by mammalian adipose tissue. Biochem. Biophys. Res. Commun. 274 (2000) 571-575
32. Fain J.N., and Madan A.K. Insulin enhances VEGF, IL-8 and PAI-1 but not IL-6 release by human adipocytes. Metabolism 54 (2005) 220-226
33. Fain J.N., and Madan A.K. Regulation of monocyte chomoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue. Int. J. Obes. (Lond.) 29 (2005) 1299-1307
34. 2 in adipose tissue from obese humans. Metabolism 50 (2001) 921-928
35. 2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture. Prostaglandins 67 (2002) 467-473
36. Fain J.N., Cheema P.S., Bahouth S.W., and Hiler M.L. Resistin release by human adipose tissue explants in primary culture. Biochem. Biophys. Res. Commun. 300 (2003) 674-678
37. Fain J.N., Madan A.K., Hiler M.L., Cheema P., and Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 (2004) 2273-2282
38. Fain J.N., Bahouth S.W., and Madan A.K. Haptoglobin release by human adipose tissue in primary culture. J. Lipid Res. 45 (2004) 536-542
39. Fain J.N., Bahouth S.W., and Madan A.K. TNFα release by the nonfat cells of human adipose tissue. Intl. J. Obes. (Lond.) 28 (2004) 616-622
40. Fain J.N., Bahouth S.W., and Madan A.K. Involvement of multiple signaling pathways in the post bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue. Biochem. Pharmacol. 69 (2005) 1315-1324
41. Fain J.N., Tichansky D.S., and Madan A.K. Transforming growth factor β1 release by human adipose tissue is enhanced in obesity. Metabolism 54 (2005) 1546-1551
42. Fain J.N., Tichansky D.S., and Madan A.K. The majority of the IL-1Ra, cathepsin S, MIF NGF, and IL-18 release by explants of human visceral adipose tissue is by the nonfat cells, not the adipocytes. Metabolism 55 (2006) 1113-1121
43. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115 (2005) 911-919
44. Festa A., D'Agostino Jr., R., Williams K., Karter A.J., Mayer-David E.J., Tracy R.P., and Haffner S.M. The relation of body fat mass and distribution to markers of chronic inflammation. Int. J. Obes. (Lond.) 25 (2001) 1407-1415
45. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 (1998) 847-850
46. Friedrichs W.E., Navarijo-Ashbaugh A.L., Bowman B.H., and Yang F. Expression and inflammatory regulation of haptoglobin gene in adipocytes. Biochem. Biophys. Res. Commun. 209 (1995) 250-256
47. Goodpaster B.H., Krishnaswami S., Harris T.B., Katsiaras A., Kritchevsky S.B., Simonsick E.M., Nevitt M., Halvoet P., and Newman A.B. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 165 (2005) 777-783
48. Gracie J.A., Robertson S.E., and McInnes I.B. Interleukin-18. J. Leukoc. Biol. 73 (2003) 213-224
49. Hak A.E., Stehouwer C.D., Bots M.L., Polderman K.H., Schalkwijk C.G., Westendorp I.C., Hofman A., and Witteman J.C. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1986-1991
50. Hannerz J., Greitz D., and Ericson K. Is there a relationship between obesity and intracranial hypertension?. Int. J. Obes. (Lond.) 19 (1995) 762-763
51. Hanusch-Enserer U., Cauza E., Spak M., Dunky A., Rosen H.R., Wolf H., Prager R., and Eibl M.M. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int. J. Obes. (Lond.) 27 (2003) 355-361
52. Hasegawa G., Ohta M., Ichida Y., Obayashi H., Shigeta M., Yamasaki M., Fukui M., Yoshikawa T., and Nakamura N. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol. 42 (2005) 104-109
53. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc. Nutr. Soc. 64 (2005) 163-169
54. Hausman G.J., Campion D.R., and Martin R.J. Search for the adipocyte precursor cell and factors that promote its differentiation. J. Lipid Res. 21 (1980) 657-670
55. Heinrich J.N., and Bravo R. The orphan mouse receptor interleukin (IL)-8R beta binds N51. Structure-function analysis using N51/IL-8 chimeric molecules. J. Biol. Chem. 270 (1995) 4987-4989
56. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem. J. 265 (1990) 621-636
57. Hellman B., Larsson S., and Westman S. Mast cell content and fatty acid metabolism in the epididymal fat pad of obese mice. Acta Physiol. Scand. 58 (1963) 255-262
58. Helmersson J., Vessby B., Larsson A., and Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109 (2004) 1729-1734
59. Hirokawa J., Sakaue S., Tagami S., Kawakami Y., Sakai M., Nishi S., and Nishihira J. Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-α. Biochem. Biophys. Res. Commun. 235 (1997) 94-98
60. Hoffmann E., Dittrich-Breiholz O., Holtmann H., and Kracht M. Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72 (2002) 847-855
61. Holdstock C., Lind L., Engstrom B.E., Ohrvall M., Sundbom M., Larsson A., and Karlsson F.A. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Int. J. Obes.(Lond.) 29 (2005) 1275-1280
62. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
63. Holtmann H., Winzen R., Holland P., Eickemeier S., Hoffman E., Wallach D., Malinin N.L., Cooper J.A., Resch K., and Kracht M. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol. Cell Biol. 19 (1999) 6742-6753
64. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
65. Iqbal N., Seshadri P., Stern L., Loh J., Kundu S., Jafar T., and Samaha F.F. Serum resistin is not associated with obesity or insulin resistance in humans. Eur. Rev. Med. Pharmacol. Sci. 9 (2005) 161-165
66. Jansson P.-A., Larsson A., Smith U., and Lonnroth P. Glycerol production in subcutaneous adipose tissue in lean and obese humans. J. Clin. Invest. 89 (1992) 1610-1617
67. Juge-Aubry C.E., Somm E., Giusti V., Pernin A., Chicheportiche R., Verdumo C., Rohner-Jeanrenaud F., Burger D., Dayer J.M., and Meier C.A. Adipose tissue is a major source of interleukin-1 receptor antagonist: Upregulation in obesity and inflammation. Diabetes 52 (2003) 1104-1110
68. Kabon B., Nagele A., Reddy D., Eagon C., Fleshman J.W., Sessler D.I., and Kurz A. Obesity decreases perioperative tissue oxygenation. Anesthesiology 100 (2004) 274-280
69. Kern P.A., Saghizadeh M., Ong J.M., Bosch R.J., Deem R., and Simsolo R.B. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95 (1995) 2111-2119
70. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E745-E751
71. Klover P.J., Clementi A.H., and Mooney R.A. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146 (2005) 3417-3427
72. Kopp H.P., Kopp C.W., Festa A., Krzyzanowska K., Kriwanek S., Minar E., Roka R., and Schernthaner G. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1042-1047
73. Kratchmarova I., Kalume D.E., Blagoev B., Scherer P.E., Podtelejnikov A.V., Molina H., Bickel P.E., Anderson J.S., Fernandez M.M., Bunkenborg J., Roepstorff P., Kristiansen K., et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell Proteomics 1 (2002) 213-222
74. Laimer M., Ebenbichler C.F., Kaser S., Sandhofer A., Weiss H., Nehoda H., Aigner F., and Patsch J.R. Markers of chronic inflammation and obesity: A prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Intl. J. Obes. (Lond.) 26 (2002) 659-662
75. Lau D.C., Dhillon B., Yan H., Szmitko P.E., and Verma S. Adipokines: Molecular links between obesity and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2031-H2041
76. Lee J.H., Chan J.L., Yiannakouris N., Kontogianni M., Estrada E., Seip R., Orlova C., and Mantzoros C.S. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, diabetic subjects. J. Clin. Endocrinol. Metab. 88 (2003) 4848-4856
77. Lin Y., Lee H., Berg A.H., Lisanti M.P., Shapiro L., and Scherer P.E. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J. Biol. Chem. 275 (2000) 24255-24263
78. Liuzzo J.P., Petanceska S.S., Moscatelli D., and Devi L.A. Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions. Mol. Med. 5 (1999) 320-333
79. Luheshi G.N., Gardner J.D., Rushforth D.A., Loudon A.S., and Rothwell N.J. Leptin actions on food intake and body temperature are mediated by IL-1. Proc. Natl. Acad. Sci. USA 96 (1999) 7047-7052
80. Manigrasso M.R., Ferroni P., Santilli F., Taraborelli T., Guagnano M.T., Michette N., and Davi G. Association between circulating adiponectin and interleukin-10 levels in android obesity. Effects of Weight. J. Clin. Endocrinol. Metab. 90 (2005) 5876-5879
81. Meier C.A., Bobbioni E., Gabay C., Assimacopoulos-Jeannet F., Golay A., and Dayer J.M. IL-1 receptor antagonist serum levels are increased in human obesity: A possible link to the resistance to leptin?. J. Clin. Endocrinol. Metab. 87 (2002) 1184-1188
82. Mick G.J., Wang X., and McCormick K. White adipocyte vascular endothelial growth factor: Regulation by insulin. Endocrinology 143 (2002) 948-953
83. Migita K., Kawabe Y., Tominaga M., Origuchi T., Aoyagi T., and Eguchi K. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest. 78 (1998) 535-539
84. Miida T., Yamada T., Yamadera T., Ozaki K., Inano K., and Okada M. Serum amyloid A protein generates pre β1 high-density lipoprotein from α-migrating high-density lipoprotein. Biochemistry 38 (1999) 16958-16962
85. Mirone L., Altomonte L., D'Agostino P., Zoli A., Barini A., and Magaro M. A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity. Clin. Rheumatol. 15 (1996) 15-19
86. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N., and Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 46 (2003) 1483-1488
87. Mocellin S., Panelli M.C., Wang E., Nagorsen D., and Marincola F.M. The dual role of IL-10. Trends Immunol. 24 (2003) 36-43
88. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., and Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J. Clin. Endocrinol. Metab. 82 (1997) 4196-4200
89. Moriwaki Y., Yamamoto T., Shibutani Y., Aoki E., Tsutsumi Z., Takahashi S., Okamura H., Koga M., Fukuchi M., and Hada T. Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy. Metabolism 52 (2003) 605-608
90. Nagaev I., and Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Commun. 285 (2001) 561-564
91. Nicklas B.J., Penninx B.W., Cesari M., Kritchevsky S.B., Newman A.B., Kanaya A.M., Pahor M., Jingzhong D., and Harris T.B. Association of visceral adipose tissue with incident myocardial infarction in older men and women. Am. J. Epidemiol. 160 (2004) 741-749
92. Nicoletti F., Conget I., Di Marco R., Speciale A.M., Morinigo R., Bendtzen K., and Gomis R. Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 44 (2001) 309-311
93. Orban A., Remaley A.T., Sampson M., Trajanoski Z., and Chrousos G.P. The differential effect of food intake and β-adrenergic stimulation on adipose-derived hormones and cytokines in man. J. Clin. Endocrinol. Metab. 84 (1999) 2126-2133
94. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., Okamoto Y., Ohashi K., Nagaretani H., Kishida K., Nishizawa H., Maeda N., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
95. Pannacciulli N., Cantatore F.P., Minenna A., Bellacicco M., Giorgino R., and De Pergola G. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int. J. Obes. (Lond.) 25 (2001) 1416-1420
96. Pedersen B.K., Steensberg A., Fischer C., Keller C., Keller P., Plomgaard P., Febbraio M., and Saltin B. Searching for the exercise factor: Is IL-6 a candidate?. J. Muscle. Res. Cell. Motil. 24 (2003) 113-119
97. Peeraully M.R., Jenkins J.R., and Trayhurn P. NGF gene expression and secretion in white adipose tissue: Regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E331-E339
98. Piche M.E., Weisnagel S.J., Corneau L., Nadeau A., Bergeron J., and Lemieux S. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes 54 (2005) 770-777
99. Poitou C., Viguerie N., Cancello R., De Matteis R., Cinti S., Stich V., Coussieu C., Gauthier E., Courtine M., Zucker J.D., Barsh G.S., Saris W., et al. Serum amyloid A: Production by human white adipocytes and regulation by obesity and nutrition. Diabetologia 48 (2005) 519-528
100. Putnam F.W. Haptoglobin. In: Putnam F.W. (Ed). "The Plasma Proteins Structure, Function, and Genetic Control". 2nd ed. Vol II (1975), Academic Press, New York 2-50
101. Rajala M.W., and Scherer P.E. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144 (2003) 3765-3773
102. Reape T.J., and Groot P.H. Chemokines and atherosclerosis. Atherosclerosis 147 (1999) 213-225
103. Reddy P. Interleukin-18: Recent advances. Curr. Opin. Hematol. 11 (2004) 405-410
104. Reddy V.Y., Zhang Q.Y., and Weiss S.J. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins, B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 92 (1995) 3849-3853
105. Rehman J., Considine R.V., Bovenkerk J.E., Li J., Slavens C.A., Jones R.M., and March K.L. Obesity is associated with increased levels of circulating hepatocyte growth factor. J. Am. Coll. Cardiol. 41 (2004) 1408-1413
106. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., Pell C.L., Johnstone B.H., Considine R.V., and March K.L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109 (2004) 1292-1298
107. Rosenbaum M., Malbon C.C., Hirsch J., and Leibel R.L. Lack of β3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J. Clin. Endocrinol. Metab. 77 (1993) 352-355
108. Rothe H., Hausmann A., Casteels K., Okamura H., Kurimoto M., Burkart V., Mathieu C., and Kolb H. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. J. Immunol. 163 (1999) 1230-1236
109. Rotter Sopasakis V., Larsson B.M., Johansson A., Holmang A., and Smith U. Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signaling in rats. Diabetologia 47 (2004) 1879-1887
110. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 100 (2003) 7265-7270
111. Savage D.B., Sewter C.P., Klenk E.S., Segal D.G., Vidal-Puig A., Considine R.V., and O'Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50 (2001) 2199-2202
112. Scaglione R., Argano C., di Chiara T., Colomba D., Parrinello G., Corrao S., Avellone G., and Licata G. Central obesity and hypertensive renal disease: Association between higher levels of BMI, circulating transforming growth factor β1 and urinary albumin excretion. Blood Press. 12 (2003) 269-276
113. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270 (1995) 26746-26749
114. Scriba P.C., Bauer M., Emmert D., Fateh-Moghadam A., Hoffman G.G., Horn K., and Pickardt C.R. Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3′-L-triiodothyronine (T3), 3,3′,5′-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, α 2-haptoglobin and complement C′3 in serum. Acta Endocrinol. (Copenh.) 91 (1979) 629-643
115. Silha J.V., Krsek M., Sucharda P., and Murphy L.J. Angiogenic factors are elevated in overweight and obese individuals. Int. J. Obes. (Lond.) 29 (2005) 1308-1314
116. Sjoholm K., Palming J., Olofsson L.E., Gummesson A., Svensson P.A., Lystig T.C., Jennische E., Brandberg J., Torgerson J.S., Carlsson B., and Carlsson L.M. A microarray search for genes predominantly expressed in human omental adipocytes: Adipose tissue as a major production site of serum amyloid A. J. Clin. Endocrinol. Metab. 90 (2005) 2233-2239
117. Skurk T., and Hauner H. Obesity and impaired fibrinolysis: Role of adipose production of plasminogen activator inhibitor-1. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 1357-1364
118. Skurk T., Herder C., Kraft I., Muller-Scholze S., Hauner H., and Kolb H. Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146 (2005) 1006-1011
119. Skurk T., Kolb H., Muller-Scholze S., Rohrig K., Hauner H., and Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur. J. Endocrinol. 152 (2005) 863-868
120. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., and Lazar M.A. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
121. Straczkowski M., Dzienis-Straczkowska S., Stepien A., Kowalska I., Szelachowska M., and Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system. J. Clin. Endocrinol. Metab. 87 (2002) 4602-4606
122. Sul H.S. Resistin/ADSF/FIZZ3 in obesity and diabetes. Trends Endocrinol. Metab. 15 (2004) 247-249
123. Swierczynski J., Korczynska J., Goyke E., Adrych K., Raczynska S., and Sledzinski Z. Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty. Obes. Surg. 15 (2005) 803-808
124. Takahashi K., Mizuarari S., Araki H., Mashiko S., Ishihara A., Kanatani A., Itadani H., and Kotani H. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 278 (2003) 46654-46660
125. Taleb S., Lacasa D., Bastard J.P., Poitou C., Cancello R., Pelloux V., Viguerie N., Benis A., Zucker J.D., Bouillot J.L., Coussieu C., Basdevant A., et al. Cathepsin S. A novel biomarker of adiposity: Relevance to atherogenesis. FASEB J. 19 (2005) 1540-1542
126. Tiret L., Godefroy T., Lubos E., Nicaud V., Tregouet D.A., Barbaux S., Schnabel R., Bickel C., Espinola-Klein C., Poirier O., Perret C., Munzel T., et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 112 (2005) 643-650
127. Trayhurn P. Endocrine and signaling role of adipose tissue: New perspective on fat. Acta Physiol. Scand. 184 (2005) 285-293
128. Trayhurn P., and Wood I.S. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutrition 92 (2004) 347-355
129. van Dielen F.M., van't Veer C., Schols A.M., Soeters P.B., Buurman W.A., and Greve J.W. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int. J. Obes. (Lond.) 25 (2001) 1759-1766
130. Vasiljeva O., Dolinar M., Pungercar J.R., Turk V., and Turk B. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans. FEBS Lett. 579 (2005) 1285-1290
131. Vazquez L.A., Pazos F., Berrazueta J.R., Fernandez-Escalante C., Garcia-Unzueta M.T., Freijanes J., and Amado J.A. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J. Clin. Endocrinol. Metab. 90 (2005) 316-322
132. Virtanen K.A., Lonnroth P., Parkkola R., Peltoniemi P., Asola M., Viljanen T., Tolvanen T., Knuuti J., Ronnemaa T., Huupponen R., and Nuutila P. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J. Clin. Endocrinol. Metab. 87 (2002) 3902-3910
133. Warne J.P. Tumour necrosis factor α: A key regulator of adipose tissue mass. J. Endocrinol. 177 (2003) 351-355
134. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119
135. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
136. Wisse B.E., Ogimoto K., Morton G.J., Wilkinson C.W., Frayo R.S., Cummings D.E., and Schwartz M.W. Physiological regulation of hypothalamic IL-1β gene expression by leptin and glucocorticoids: Implications for energy homeostasis. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E1107-E1113
137. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
138. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 972-978
139. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
140. Zhang W., Smith C., Howlett C., and Stanimirovic D. Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1β. J. Cereb. Blood Flow Metab. 6 (2000) 967-978
141. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
142. Zozulinska D., Majchrzak A., Sobieska M., Wiktorowicz K., and Wierusz-Wysocka B. Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42 (1999) 117-118